Senté, Inc. Announces Attendance at the 2012 ASDS Annual Meeting
SAN DIEGO, Oct. 8, 2012 /PRNewswire-iReach/ -- Senté, Inc., a science-based cosmeceutical company, today announced that the company will be attending and exhibiting at the 2012 American Society for Dermatologic Surgery Annual Meeting from Thursday, October 11th to Saturday, October 13th, at the Hyatt Regency Atlanta in Atlanta, Georgia.
Senté, Inc. will be showcasing the company's newly launched dermatological product, Senté Dermal Repair Cream, which features a proprietary formulation of the active ingredient heparan sulfate (HS). HS is the most biologically active of the glycoproteins that reside in human skin. The biologically active glycoproteins used in Senté Dermal Repair Cream help promote cell renewal, facilitate new collagen development, increase skin hydration, gradually lighten the appearance of pigmented lesions and soothe irritated skin.
"We are thrilled to be participating in the 2012 ASDS Annual Meeting, where we have the opportunity to connect and collaborate with the leaders in dermatology," said Marie R. Giroux, President, Senté, Inc. "Our objective is to better understand and relate to the needs of these leading practices, and to educate physicians on how Senté can compliment and fit their patients needs."
Senté's product line is targeted and sold through dermatologists and aesthetic practices throughout the United States.
About Senté, Inc.
Senté, Inc. is a privately held cosmeceutical company engaged in the development of targeted and differentiated medical skincare products based on glycoproteins. The company is committed to delivering novel products for a variety of dermatological concerns. Senté, Inc. was founded in 2007 and is based in San Diego, California. More information on the company can be found at http://www.sentelabs.com.
Media Contact: Aaron Hasnain Senté, Inc., (760) 753-5400, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Sente, Inc.